1. Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 6, 1237–1245. doi: 10.1016/0092-8674(92)90644-R .
2. Prives, C., & Hall, P. A. (1999). The p53 pathway. The Journal of Pathology, 187, 112–126. doi:10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3.
3. Moll, U. M., & Petrenko, O. (2003). The MDM2–p53 interaction. Molecular Cancer Research, 1, 1001–1008.
4. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H., Parry, D., et al. (1995). Complex structure and regulation of the P16 (MTS1) locus. Cancer Research, 55, 2988–2994.
5. Mao, L., Merlo, A., Bedi, G., Shapiro, G. I., Edwards, C. D., Rollins, B. J., et al. (1995). A novel p16INK4A transcript. Cancer Research, 55, 2995–2997.